• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Gynecologic Oncology Reports >Advancing clinical research globally: Cervical cancer research network from Mexico
【24h】

Advancing clinical research globally: Cervical cancer research network from Mexico

机译：全球推进临床研究：来自墨西哥的宫颈癌研究网络

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cervical cancer is the fourth most common cancer in women with 85% of the mortality burden occurring in less-developed regions of the world. The Cervix Cancer Research Network (CCRN) was founded by the Gynecologic Cancer InterGroup (GCIG) with a mission to improve outcomes in cervix cancer by increasing access to high-quality clinical trials worldwide, with particular attention to less-developed, underrepresented sites. The CCRN held its second international educational symposium in Mexico City with ninety participants from fifteen Latin America countries in January 2017. The purpose of this symposium was to advance knowledge in cervix cancer therapy, promote recruitment to CCRN clinical trials, and to identify relevant future CCRN clinical trial concepts that could improve global care standards for women with cervical cancer. Highlights ? Cervix cancer is the fourth most common cancer in women worldwide with up to an 18-fold disparity in mortality rates. ? The Cervix Cancer Research Network (CCRN) aims to increase access to clinical trials in order to improve outcomes for women. ? The 2nd CCRN international symposium was held in Mexico City including 90 participants from 15 Latin American countries. ? CCRN clinical trials were discussed, including new trials proposed of hypofractionation and HPV targeted therapy.
机译：宫颈癌是女性中第四大常见癌症，其死亡率的85％发生在世界欠发达地区。子宫颈癌研究网络（CCRN）由妇科癌变研究小组（GCIG）建立，其使命是通过增加全球范围内的高质量临床试验的机会来改善子宫颈癌的预后，尤其是关注欠发达，代表性不足的研究地点。 CCRN于2017年1月在墨西哥城举行了第二届国际教育研讨会，来自15个拉丁美洲国家的90名与会者参加了该研讨会。该研讨会的目的是增进子宫颈癌治疗的知识，促进CCRN临床试验的招募并确定相关的未来CCRN可以改善宫颈癌女性的全球护理标准的临床试验概念。强调 ？子宫颈癌是全世界女性中第四大最常见的癌症，死亡率差距高达18倍。 ？宫颈癌研究网络（CCRN）旨在增加获得临床试验的机会，以改善女性的结局。 ？第二届CCRN国际研讨会在墨西哥城举行，来自15个拉丁美洲国家的90名与会者参加了会议。 ？讨论了CCRN临床试验，包括提议的超分割和HPV靶向治疗的新试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号